Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-status

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Oct 22

PMID 22016763

Citations 49

Authors

Robin Wood

Stephen D Lawn

Judy Caldwell

Richard Kaplan

Keren Middelkoop

Linda-Gail Bekker

Affiliations

Soon will be listed here.

Abstract

Aim: To describe the burden of tuberculosis (TB) in Cape Town by calculating TB incidence rates stratified by age and HIV-status, assessing the contribution of retreatment disease and estimating the cumulative lifetime TB risk in HIV-negative individuals.

Methods: Details of TB cases were abstracted from the 2009 electronic TB register. Population denominators were estimated from census data and actuarial estimates of HIV prevalence, allowing calculation of age-specific and HIV-stratified TB notification rates.

Results: The 2009 mid-year population was 3,443,010 (3,241,508 HIV-negative and 201,502 HIV-positive individuals). There were 29,478 newly notified TB cases of which 56% were laboratory confirmed. HIV status was recorded for 87% of cases and of those with known HIV-status 49% were HIV-negative and 51% were positive. Discrete peaks in the incidence of non-HIV-associated TB occurred at three ages: 511/100,000 at 0-4 years of age, 553/100,000 at 20-24 years and 628/100,000 at 45-49 years with 1.5%, 19% and 45% being due to retreatment TB, respectively. Only 15.5% of recurrent cases had a history of TB treatment failure or default. The cumulative lifetime risks in the HIV-negative population of all new TB episodes and new smear-positive TB episodes were 24% and 12%, respectively; the lifetime risk of retreatment disease was 9%. The HIV-positive notification rate was 6,567/100,000 (HIV-associated TB rate ratio = 17). Although retreatment cases comprised 30% of the HIV-associated TB burden, 88% of these patients had no history of prior treatment failure or default.

Conclusions: The annual burden of TB in this city is huge. TB in the HIV-negative population contributed almost half of the overall disease burden and cumulative lifetime risks were similar to those reported in the pre-chemotherapy era. Retreatment TB contributed significantly to both HIV-associated and non-HIV-associated TB but infrequently followed prior inadequate treatment. This likely reflects ongoing TB transmission to both HIV-negative and positive individuals.

Citing Articles

Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures.

Suliman S, Jaganath D, DiNardo A Clin Infect Dis. 2023; 77(3):450-452.

PMID: 37144361 PMC: 10425193. DOI: 10.1093/cid/ciad270.

Prevalence, Incidence, and Characteristics of Tuberculosis Among Known Diabetes Patients - A Prospective Cohort Study in 10 Sites, 2013-2015.

Cheng J, Yu Y, Ma Q, Wang Z, Zhou Q, Zhang G China CDC Wkly. 2022; 4(3):41-46.

PMID: 35586458 PMC: 8796720. DOI: 10.46234/ccdcw2022.004.

Discovery of a novel type IIb RelBE toxin-antitoxin system in Mycobacterium tuberculosis defined by co-regulation with an antisense RNA.

Dawson C, Cummings J, Starkey J, Slayden R Mol Microbiol. 2022; 117(6):1419-1433.

PMID: 35526138 PMC: 9325379. DOI: 10.1111/mmi.14917.

Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.

Zurcher K, Riou J, Morrow C, Ballif M, Koch A, Bertschinger S J Infect Dis. 2022; 225(9):1642-1652.

PMID: 35039860 PMC: 9071349. DOI: 10.1093/infdis/jiab534.

Tuberculosis prevention in children: a prospective community-based study in South Africa.

Mandalakas A, Hesseling A, Kay A, du Preez K, Martinez L, Ronge L Eur Respir J. 2020; 57(4).

PMID: 33122339 PMC: 8060782. DOI: 10.1183/13993003.03028-2020.

References

Lawn S, Bekker L, Middelkoop K, Myer L, Wood R . Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis. 2006; 42(7):1040-7. DOI: 10.1086/501018. View

Shanaube K, Sismanidis C, Ayles H, Beyers N, Schaap A, Lawrence K . Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One. 2009; 4(11):e7749. PMC: 2771909. DOI: 10.1371/journal.pone.0007749. View

Uys P, van Helden P, Hargrove J . Tuberculosis reinfection rate as a proportion of total infection rate correlates with the logarithm of the incidence rate: a mathematical model. J R Soc Interface. 2008; 6(30):11-5. PMC: 2610322. DOI: 10.1098/rsif.2008.0184. View

Vynnycky E, Fine P . Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol. 2000; 152(3):247-63. DOI: 10.1093/aje/152.3.247. View

Middelkoop K, Bekker L, Morrow C, Zwane E, Wood R . Childhood tuberculosis infection and disease: a spatial and temporal transmission analysis in a South African township. S Afr Med J. 2010; 99(10):738-43. PMC: 2932468. View

Charalambous S, Grant A, Moloi V, Warren R, Day J, van Helden P . Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008; 12(8):942-8. View

Kritzinger F, den Boon S, Verver S, Enarson D, Lombard C, Borgdorff M . No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health. 2009; 14(2):136-42. DOI: 10.1111/j.1365-3156.2008.02213.x. View

Wood R, Johnstone-Robertson S, Uys P, Hargrove J, Middelkoop K, Lawn S . Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. Clin Infect Dis. 2010; 51(4):401-8. PMC: 3101801. DOI: 10.1086/655129. View

Wood R, Liang H, Wu H, Middelkoop K, Oni T, Rangaka M . Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis. 2010; 14(4):406-12. PMC: 2837545. View

10.

Verver S, Warren R, Beyers N, Richardson M, van der Spuy G, Borgdorff M . Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005; 171(12):1430-5. DOI: 10.1164/rccm.200409-1200OC. View

11.

Peto R, Matthews T . Tuberculosis Control Programme Practical Guidelines, 1996--treatment regimens. S Afr Med J. 1996; 86(5):560, 562. View

12.

Lawn S, Fraenzel A, Kranzer K, Caldwell J, Bekker L, Wood R . Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. S Afr Med J. 2011; 101(4):258-62. DOI: 10.7196/samj.4392. View

13.

Abbey H . An examination of the Reed-Frost theory of epidemics. Hum Biol. 1952; 24(3):201-33. View

14.

Middelkoop K, Bekker L, Myer L, Dawson R, Wood R . Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. Clin Infect Dis. 2008; 47(3):349-55. PMC: 3816246. DOI: 10.1086/589750. View

15.

Vynnycky E, Fine P . Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int J Epidemiol. 1999; 28(2):327-34. DOI: 10.1093/ije/28.2.327. View

16.

Sonnenberg P, Murray J, Glynn J, Shearer S, Kambashi B, Godfrey-Faussett P . HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001; 358(9294):1687-93. DOI: 10.1016/S0140-6736(01)06712-5. View

17.

Wood R, Lawn S, Johnstone-Robertson S, Bekker L . Tuberculosis control has failed in South Africa--time to reappraise strategy. S Afr Med J. 2011; 101(2):111-4. DOI: 10.7196/samj.4587. View

18.

Van Rie A, Warren R, Richardson M, Victor T, Gie R, Enarson D . Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999; 341(16):1174-9. DOI: 10.1056/NEJM199910143411602. View

19.

Wiker H, Mustafa T, Bjune G, Harboe M . Evidence for waning of latency in a cohort study of tuberculosis. BMC Infect Dis. 2010; 10:37. PMC: 2843612. DOI: 10.1186/1471-2334-10-37. View